N/A
Completed N=44
Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.
Source: ClinicalTrials.gov NCT02330172 ↗Enrolled (actual)
44
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Laryngoscopic Score — 1; 0; 11; 0 Participants — p=0.05
Summary
This study aims to make a comparison of surgical condition and recovery time between rocuronium 0.45 mg/kg and neostigmine group and rocuronium 0.9 mg/kg and sugammadex group.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Laryngoscopic Score |
1; 0; 11; 0; 9; 19 | 0.05 |
| SECONDARY Recovery Time From Neuromuscular Blockade |
9.9; 2.1 | 0.05 |
Eligibility Criteria
Inclusion Criteria
- American Society of Anesthesiologist Physical status classification 1 or 2 elective laryngeal microsurgery under general anesthesia
Exclusion Criteria
- BMI >25 or 40 IU/L, Cr > 1.4 mg/dl
Data sourced from ClinicalTrials.gov (NCT02330172). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.